Walleye Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Trading’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,100	Closed	-$1M	–	4776
2023 Q4	$1M	Buy	+3,100	New	+$972K	﹤0.01%	2463
2022 Q2	–	Sell	-400	Closed	-$225K	–	5131
2022 Q1	$225K	Sell	400 -500	-56%	-$301K	﹤0.01%	3690
2021 Q4	$680K	Buy	900 +500	+125%	+$374K	﹤0.01%	2633
2021 Q3	$298K	Sell	400 -400	-50%	-$300K	﹤0.01%	3457
2021 Q2	$515K	Hold	800	–	–	﹤0.01%	2879
2021 Q1	$457K	Sell	800 -200	-20%	-$118K	﹤0.01%	2738
2020 Q4	$583K	Buy	+1,000	New	+$570K	﹤0.01%	2519
2020 Q3	–	Sell	-600	Closed	-$271K	–	4105
2020 Q2	$271K	Sell	600 -500	-45%	-$221K	﹤0.01%	2836
2020 Q1	$386K	Buy	1,100 +500	+83%	+$184K	﹤0.01%	2073
2019 Q4	$222K	Buy	+600	New	+$212K	﹤0.01%	3080
2019 Q3	–	Sell	-600	Closed	-$188K	–	4025
2019 Q2	$188K	Buy	+600	New	+$180K	﹤0.01%	2988

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Walleye Trading's BIO Position: Q4 2022 in Review

Walleye Trading sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2022, closing a stake of 918 shares — an estimated $383K sold.

Walleye Trading first reported a position in BIO in Q2 2015 and held it in 14 quarters. The position peaked at $592K in Q4 2021. 470 funds tracked by Wall St. Rank hold BIO as of Q4 2022.

Walleye Trading reported no remaining Bio-Rad Laboratories Class A position as of Q4 2022 after selling out during the quarter.
Walleye Trading sold 918 Bio-Rad Laboratories Class A shares in Q4 2022, an estimated $383K.
Walleye Trading first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 14 quarters.
Walleye Trading's Bio-Rad Laboratories Class A position peaked at $592K in Q4 2021.
470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.